Author/Creator: Hehlgans, Stephanie - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Hehlgans, Stephanie

1. Advances in nanotechnology-based platforms for survivin-targeted drug discovery. (3rd July 2022)

Authors:: George, Rosemol; Hehlgans, Stephanie; Fleischmann, Maximillian; Rödel, Claus; Fokas, Emmanouil; Rödel, Franz
Journal:: Expert opinion on drug discovery
Issue:: Volume 17:Number 7(2022)
Page Start:: 733
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Mitotic arrest and slippage induced by pharmacological inhibition of Polo‐like kinase 1. Issue 1 (11th August 2014)

Authors:: Raab, Monika; Krämer, Andrea; Hehlgans, Stephanie; Sanhaji, Mourad; Kurunci-Csacsko, Elisabeth; Dötsch, Christina; Bug, Gesine; Ottmann, Oliver; Becker, Sven; Pachl, Fiona; Kuster, Bernhard; Strebhardt, Klaus
Journal:: Molecular oncology
Issue:: Volume 9:Issue 1(2015:Jan.)
Page Start:: 140
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Modulation of inflammation by low and high doses of ionizing radiation: Implications for benign and malign diseases. Issue 2 (28th November 2015)

Authors:: Frey, Benjamin; Hehlgans, Stephanie; Rödel, Franz; Gaipl, Udo S.
Journal:: Cancer letters
Issue:: Volume 368:Issue 2(2016)
Page Start:: 230
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2. (1st May 2017)

Authors:: Badawi, Amel; Hehlgans, Stephanie; Pfeilschifter, Josef; Rödel, Franz; Eberhardt, Wolfgang
Journal:: Cancer letters
Issue:: Volume 393(2017)
Page Start:: 103
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗